SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bohemian Investments LLC – ‘4’ for 4/25/14 re: Omni Bio Pharmaceutical, Inc.

On:  Thursday, 4/9/15, at 6:10pm ET   ·   For:  4/25/14   ·   Accession #:  1079974-15-257   ·   File #:  0-52530

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/09/15  Bohemian Investments LLC          4                      1:10K  Omni Bio Pharmaceutical, Inc.     Edgar.Tech Fili… Svcs/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Ownership Document --                               HTML      3K 
                form4bohemianomni_3192015.xml/3.6                                




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Ownership Document
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Bohemian Investments LLC

(Last)(First)(Middle)
262 EAST MOUNTAIN AVE.

(Street)
FORT COLLINSCO80524

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
OMNI BIO PHARMACEUTICAL, INC. [ OMBP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
4/25/14
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Convertible Note$0.2 12/12/14P (1) 2,500,000 12/12/14 4/24/15Common Stock2,500,000$500,00011,000,000D
Convertible Note$0.2 1/30/15P (2) 2,500,000 4/25/14 4/24/15Common Stock10,000,000$2,000,00011,000,000D
Convertible Note$0.2 1/30/15P (2) 2,500,000 4/25/14 12/17/19Common Stock10,000,000$2,000,00011,000,000D
Convertible Note$0.2 3/12/15P (3) 1,500,000 4/25/14 12/17/19Common Stock11,500,000$2,300,00012,500,000D
Explanation of Responses:
(1)  Advance of $500,000 under the previously disclosed $2,000,000 Secured Convertible Promissory Note resulting in total drawn principal of $2,000,000.
(2)  Amendment and restatement of the previously reported $2,000,000 Secured Convertible Promissory Note for the purpose of extending the contractual conversion to December 17, 2019 and revising the conversion rights such that the principal and the accrued interest may automatically convert at a purchase price per share equal to the lessor of $0.20 or the lowest price paid for new securities in a minimum $6,000,000 capital raise.
(3)  Amend and restatement of the previously reported $2,000,000 Secured Convertible Promissory Note for the purpose of increasing the principal of the note by $300,000 for a total of $2,300,000 and for advancing the $300,000.
BOCO Investments, LLC By: Bohemian Asset Management, Inc., its Manager /s/ Joseph C. Zimlich, President 4/9/15
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    P    Open market or private purchase of non-derivative or derivative security.

Top
Filing Submission 0001079974-15-000257   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 8:13:48.1am ET